Lawsuits allege GLP-1 drugs cause serious harm amid data gaps
Scant data on adverse effects complicates scientific and legal questions regarding the frequency of serious harms from GLP-1 medications.
This story has stopped developing; this page is its permanent record. More from that day
The story so far
1 publisher has covered this in 1 article since 10 Oct 2026. NPR Health published first, on 10 October at 11:00 UTC.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
Sources
Every article we clustered into this story. Headlines link to the publisher.